↓ Skip to main content

Cochrane Database of Systematic Reviews

Trifluoperazine versus low‐potency first‐generation antipsychotic drugs for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, July 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

blogs
1 blog
twitter
6 X users
facebook
1 Facebook page
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
121 Mendeley
Title
Trifluoperazine versus low‐potency first‐generation antipsychotic drugs for schizophrenia
Published in
Cochrane database of systematic reviews, July 2014
DOI 10.1002/14651858.cd009396.pub2
Pubmed ID
Authors

Magdolna Tardy, Markus Dold, Rolf R Engel, Stefan Leucht

Abstract

Antipsychotic drugs are the core treatment for schizophrenia. Treatment guidelines state that there is no difference in efficacy between any other antipsychotic compounds, however, low-potency antipsychotic drugs are often perceived as less efficacious than high-potency compounds by clinicians, and they also seem to differ in their side-effects.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 121 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 2%
Unknown 119 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 21 17%
Student > Bachelor 18 15%
Student > Doctoral Student 12 10%
Researcher 9 7%
Student > Ph. D. Student 8 7%
Other 18 15%
Unknown 35 29%
Readers by discipline Count As %
Medicine and Dentistry 31 26%
Psychology 17 14%
Nursing and Health Professions 11 9%
Pharmacology, Toxicology and Pharmaceutical Science 8 7%
Social Sciences 3 2%
Other 7 6%
Unknown 44 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 August 2020.
All research outputs
#2,842,971
of 25,934,828 outputs
Outputs from Cochrane database of systematic reviews
#5,443
of 13,163 outputs
Outputs of similar age
#27,117
of 241,599 outputs
Outputs of similar age from Cochrane database of systematic reviews
#99
of 232 outputs
Altmetric has tracked 25,934,828 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,163 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.2. This one has gotten more attention than average, scoring higher than 58% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 241,599 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 232 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.